The nanoB2A Group

The nanoB2A Group focuses on the development of photonic and nanomechanical nanobiosensor devices of high sensitivity for label-free detection; biofunctionalization of surfaces; and the integration in lab-on-a-chip microsystems for real field diagnostics applications.

What We Do

We develop biosensors based on plasmonics, evanescent wave sensing and on nanomechanical changes, with high sensitivity and selectivity.

Bioanalytical Aplications

The Bioanalytical Applications research activities cover the detection of a wide range of molecules, of high interest in diverse fields as clinical diagnostic, environmental control, genomic and proteomic, under laboratory and real conditions and using the biosensor devices developed within the Group.

Early Detection of Diseases and Pathogens

Integration of multibiosensor arrays on Lab-on-a-chip platforms will allow the early detection of diseases and pathogens (in vitro and in-vivo).

Lab Gallery

Lab Gallery

Setup Gallery

Setup Gallery

Devices Gallery

DevicesGallery

News

Invited presentation at “VIII Congreso de la Federación Española de Biotecnólogos”

Next July 9th-11th  in Barcelona, Prof. Laura Lechuga will deliver a lecture title: “Nanobiotechnology for advanced nanodiagnostics and nanotherapy”

Prof. Laura Lechuga: Chair of the Biophotonics and Biomedical Applications Symphosium at LAOP 2014

The Latin America Optics & Photonics Conference (LAOP) is the major conference sponsored by the Optical Society (OSA) in Latin America. In its third time the conference will be hosted in Cancun, Mexico from November 16-21

The effects of lipids and surfactants on TLR5-proteoliposome functionality for flagellin detection using surface plasmon resonance biosensing

Interview Prof. Laura Lechuga in “La Vanguardia.com”: “La ciencia en España está a punto de entrar en la UCI”

Prof Laura Lechuga is confident that in the near future, a portable device for early diagnosis of diseases such as malaria or cancer will be launched in the market.